News | Belite Bio Launching Phase 3 Clinical Trial for Stargardt Disease Drug from Foundation Fighting Blindness

News | Belite Bio Launching Phase 3 Clinical Trial for Stargardt Disease Drug

1 minutes Posted Aug 29, 2022 at 1:26 pm.

0:00

1:51

Share at current time

Show notes

The company’s drug is designed to reduce accumulation of toxins that cause vision loss.